ERIS - IntraDay Trade Analysis with Live Signals
Last Updated Time : 20 Dec 25, 07:02 am
Back to IntraDay Trade ListIntraDay Trade Rating: 3.4
| Stock Code | ERIS | Market Cap | 21,478 Cr. | Current Price | 1,577 ₹ | High / Low | 1,910 ₹ |
| Stock P/E | 76.2 | Book Value | 203 ₹ | Dividend Yield | 0.47 % | ROCE | 6.86 % |
| ROE | 3.02 % | Face Value | 1.00 ₹ | DMA 50 | 1,603 ₹ | DMA 200 | 1,564 ₹ |
| Chg in FII Hold | -1.18 % | Chg in DII Hold | 1.18 % | PAT Qtr | 150 Cr. | PAT Prev Qtr | 100.0 Cr. |
| RSI | 44.5 | MACD | -10.2 | Volume | 18,565 | Avg Vol 1Wk | 49,024 |
| Low price | 1,097 ₹ | High price | 1,910 ₹ | PEG Ratio | -1.76 | Debt to equity | 0.79 |
| 52w Index | 59.0 % | Qtr Profit Var | 432 % | EPS | 20.7 ₹ | Industry PE | 30.6 |
📊 Analysis: ERIS shows weak intraday potential due to low volume (18,565 vs avg 49,024) and bearish MACD (-10.2). Current price (₹1,577) is slightly below the 50 DMA (₹1,603) but above the 200 DMA (₹1,564), indicating neutral to mildly bearish short-term momentum. RSI at 44.5 suggests the stock is neither oversold nor overbought, but institutional selling (FII -1.18%) adds pressure.
💡 Optimal Buy Price: ₹1,565–₹1,575 (near support zone).
🎯 Profit Exit Levels: ₹1,595 (first resistance), ₹1,610 (second resistance).
🛡️ Stop-Loss: ₹1,555 (below intraday support).
⏱️ If Already Holding: Exit intraday if price fails to sustain above ₹1,575 with weak momentum or if volume remains below average. Consider booking profits near ₹1,595–₹1,610 if momentum improves during the session.
Positive
- 📈 Strong quarterly PAT growth from ₹100 Cr. to ₹150 Cr. (432% variation).
- 💰 DII holding increased by 1.18%, showing domestic investor confidence.
- 📊 EPS at ₹20.7 reflects earnings improvement.
Limitation
- ⚠️ High P/E (76.2) compared to industry average (30.6), suggesting overvaluation.
- 📉 Weak ROCE (6.86%) and ROE (3.02%) indicate poor capital efficiency.
- 🔻 MACD negative signals bearish short-term momentum.
- 📊 Low trading volume reduces intraday strength.
- 💳 Debt-to-equity ratio (0.79) is relatively high compared to peers.
Company Negative News
- 📰 No major negative news reported, but weak fundamentals and high debt raise concerns.
Company Positive News
- 📰 Strong quarterly profit growth supports positive sentiment despite valuation concerns.
Industry
- 🏭 Pharma sector trading at PE 30.6, significantly lower than ERIS’s valuation.
- 📈 Industry demand supported by healthcare expansion and rising domestic consumption.
Conclusion
⚖️ ERIS is fundamentally overvalued with weak efficiency metrics, but strong quarterly profit growth provides some support. Intraday trading opportunity is limited due to low volume and bearish momentum. Cautious entry near ₹1,565–₹1,575 with profit exits at ₹1,595–₹1,610 is possible, but strict stop-loss at ₹1,555 is essential.
Would you like me to extend this into a peer benchmarking overlay comparing ERIS against other pharma stocks, or should we focus on basket rotation signals for intraday workflow optimization?
Back to IntraDay Trade ListNIFTY 50 - Today Top Intraday Trade Stock Picks
NEXT 50 - Today Top Intraday Trade Stock Picks
MIDCAP - Today Top Intraday Trade Stock Picks
SMALLCAP - Today Top Intraday Trade Stock Picks